Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CytRx Corporation (CYTR)

0.606159   0.005 (0.81%) 01-18 15:59
Open: 0.6 Pre. Close: 0.6013
High: 0.63 Low: 0.591
Volume: 127,689 Market Cap: 20M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.63 - 0.633 0.633 - 0.636
Low: 0.583 - 0.586 0.586 - 0.589
Close: 0.595 - 0.6 0.6 - 0.605

Technical analysis

as of: 2019-01-18 4:30:38 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are.
Target: Six months: 0.74     One year: 0.87
Support: Support1: 0.45    Support2: 0.33
Resistance: Resistance1: 0.63    Resistance2: 0.74
Pivot: 0.55
Moving Average: MA(5): 0.60     MA(20): 0.51
MA(100): 0.76     MA(250): 1.20
MACD: MACD(12,26): 0.02     Signal(9):
Stochastic oscillator: %K(14,3): 89.59     %D(3): 90.81
RSI: RSI(14): 58.34
52-week: High: 2.35  Low: 0.33  Change(%): -67.2
Average Vol(K): 3-Month: 17201  10-Days: 12787

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
CYTR has closed below upper band by 27.7%. Bollinger Bands are 11.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-01-14T09:00:00-05:00
CytRx Corporation Highlights Aldoxorubicin's Inclusion In New NantCell Inc. Colorectal Cancer Clinical Trial

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 33.64
Shares Float (M) 32.26
% Held by Insiders
% Held by Institutions 11.20
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est. Current Year -0.500
EPS Est. Next Year -0.410
EPS Est. Next Quarter
Forward EPS 1.#IO
Book Value (p.s.) 0.840
PEG Ratio
Profit Margin
Operating Margin -4317.84
Return on Assets (ttm) -36.1
Return on Equity (ttm) -68.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -15.06
Levered Free Cash Flow (M) -17.59

Stock Valuations

P/E
P/E Growth Ratio
P/BV 0.71
P/S 2019409280.00
P/CF -1.34

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2008-07-03
Forward Dividend
Last Split Date 2017-11-01
Last Split Ratio -1e+010
7 Binary Options
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.